Subsequent Transplant or Cellular Therapy

Is this the report of a second or subsequent transplant or cellular therapy for the same disease?

Indicate if the reporting of this infusion is of a subsequent infusion for the same disease subtype.

Report No in any of the following scenarios:
• This is the first infusion reported to the CIBMTR;
• This is the first infusion given to treat the recipient’s current disease; or
• This is a second or subsequent infusion for the same disease and this baseline disease insert was not completed for the previous transplant (e.g., recipient was on TED track for the prior infusion, prior infusion was autologous with no consent, etc.).

If this is a report of a subsequent infusion for the same disease and this baseline lymphoma disease insert was completed previously, report Yes and continue with Disease Assessment at Transformation.

Section Updates:

Question Number	Date of Change	Add/Remove/Modify	Description	Reasoning (If applicable)
.	.	.	.	.

Copyright © 2004-2025 The Medical College of Wisconsin, Inc. and NMDP. All Rights Reserved.
CIBMTR® (Center for International Blood and Marrow Transplant Research) is a research collaboration between the Medical College of Wisconsin and NMDP.